Metzger Michael A
SEC CIK 1507220 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SNDX | Syndax Pharmaceuticals Inc | Pres, COO, Dir | 517.2K | — | $12.72M | 37 | 2021-09-13 | 2026-07-08 |
Most active insiders at SNDX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Metzger Michael A | CEO, Dir | — | $1.43M |
| 2 | Botwood Nicholas A.J. | CMO, Head of R, D | — | $1.18M |
| 3 | Goldan Keith A. | CFO | — | $137.0K |
| 4 | Rizo Aleksandra | Dir | — | — |
| 5 | Jarrett Jennifer | Dir | — | — |
| 6 | Huber Martin H. Jr. | Dir | — | — |
| 7 | Legault Pierre | Dir | — | — |
| 8 | Katkin Keith | Dir | — | — |
| 9 | Podlesak Dennis | Dir | — | — |
Transactions 37
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-07-09 16:54 | 2026-07-08 | SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | CEO, Dir | M - OptEx | $6.38 | +32.4K | 517.2K | +7% | +$206.6K |
| DT | 2026-07-09 16:54 | 2026-07-08 | SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | CEO, Dir | S - Sale+OE | $24.24 | -32.4K | 484.8K | -6% | -$784.8K |
| 2026-06-02 16:30 | 2026-06-01 | SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | CEO, Dir | S - Sale | $18.99 | -6,847 | 484.8K | -1% | -$130.0K | |
| 2026-02-10 | 2026-02-09 | SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | CEO, Dir | S - Sale | $21.03 | -17.2K | 491.7K | -3% | -$360.9K | |
| DM | 2026-02-06 | 2026-02-04 | SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | CEO, Dir | A - Grant | $0.00 | +217.6K | 516.3K | +73% | $0 |
| D | 2026-02-06 | 2026-02-06 | SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | CEO, Dir | S - Sale | $20.62 | -7,412 | 508.8K | -1% | -$152.8K |
| DT | 2025-09-08 | 2025-09-08 | SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | CEO, Dir | S - Sale+OE | $16.41 | -157.3K | 298.7K | -34% | -$2.58M |
| DT | 2025-09-08 | 2025-09-08 | SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | CEO, Dir | M - OptEx | $10.90 | +157.3K | 456.0K | +53% | +$1.71M |
| 2025-07-18 | 2025-07-16 | SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | CEO, Dir | S - Sale | $9.29 | -7,534 | 298.7K | -2% | -$70.0K | |
| D | 2025-03-17 | 2025-03-14 | SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | CEO, Dir | M - OptEx | $7.20 | +6,074 | 306.2K | +2% | +$43.7K |
| DT | 2025-03-06 | 2025-03-04 | SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | CEO, Dir | S - Sale+OE | $15.05 | -7,814 | 300.1K | -3% | -$117.6K |
| DT | 2025-03-06 | 2025-03-04 | SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | CEO, Dir | M - OptEx | $7.20 | +7,814 | 307.9K | +3% | +$56.3K |
| 2025-02-12 | 2025-02-10 | SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | CEO, Dir | S - Sale | $15.50 | -13.3K | 300.1K | -4% | -$206.0K | |
| DM | 2025-02-07 | 2025-02-05 | SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | CEO, Dir | A - Grant | $0.00 | +149.5K | 224.4K | +200% | $0 |
| DM | 2024-02-09 | 2024-02-07 | SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | CEO, Dir | A - Grant | $0.00 | +146.2K | 163.9K | +828% | $0 |
| D | 2023-02-08 | 2023-02-06 | SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | CEO, Dir | S - Sale+OE | $27.64 | -5,959 | 17.7K | -25% | -$164.7K |
| D | 2023-02-08 | 2023-02-06 | SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | CEO, Dir | M - OptEx | $6.38 | +5,959 | 23.6K | +34% | +$38.0K |
| D | 2022-10-07 | 2022-10-06 | SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | CEO, Dir | S - Sale+OE | $25.29 | -16.2K | 17.7K | -48% | -$410.5K |
| D | 2022-10-07 | 2022-10-06 | SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | CEO, Dir | M - OptEx | $8.77 | +16.2K | 33.9K | +92% | +$142.3K |
| DM | 2022-10-04 | 2022-09-30+ | SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | CEO, Dir | M - OptEx | $8.77 | +33.8K | 20.5K | New | +$296.2K |
| DM | 2022-10-04 | 2022-09-30+ | SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | CEO, Dir | S - Sale+OE | $25.02 | -33.8K | 17.7K | -66% | -$844.9K |
| DM | 2022-07-27 | 2022-07-25 | SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | CEO, Dir | S - Sale+OE | $21.06 | -31.6K | 17.7K | -64% | -$665.5K |
| DM | 2022-07-27 | 2022-07-25 | SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | CEO, Dir | M - OptEx | $6.38 | +31.6K | 29.5K | New | +$201.6K |
| DM | 2022-07-08 | 2022-07-06+ | SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | CEO, Dir | M - OptEx | $6.38 | +15.1K | 17.8K | +570% | +$96.4K |
| DM | 2022-07-08 | 2022-07-06+ | SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | CEO, Dir | S - Sale+OE | $21.07 | -15.1K | 17.7K | -46% | -$318.3K |
| DM | 2021-12-20 | 2021-12-16+ | SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | Pres, COO, Dir | S - Sale+OE | $19.94 | -85.4K | 17.7K | -83% | -$1.70M |
| DM | 2021-12-20 | 2021-12-16+ | SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | Pres, COO, Dir | M - OptEx | $7.64 | +85.4K | 19.3K | New | +$652.3K |
| DM | 2021-12-15 | 2021-12-13 | SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | Pres, COO, Dir | S - Sale+OE | $19.05 | -36.6K | 17.7K | -67% | -$697.4K |
| DM | 2021-12-15 | 2021-12-13 | SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | Pres, COO, Dir | M - OptEx | $6.43 | +36.6K | 19.7K | New | +$235.2K |
| DM | 2021-10-27 | 2021-10-25+ | SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | Pres, COO, Dir | M - OptEx | $7.20 | +61.0K | 34.0K | New | +$439.2K |
| DM | 2021-10-27 | 2021-10-25+ | SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | Pres, COO, Dir | S - Sale+OE | $19.15 | -61.0K | 17.7K | -78% | -$1.17M |
| D | 2021-09-28 | 2021-09-27 | SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | Pres, COO, Dir | S - Sale+OE | $19.51 | -24.4K | 17.7K | -58% | -$476.8K |
| D | 2021-09-28 | 2021-09-27 | SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | Pres, COO, Dir | M - OptEx | $7.20 | +24.4K | 42.1K | +138% | +$175.9K |
| DM | 2021-09-22 | 2021-09-20+ | SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | Pres, COO, Dir | S - Sale+OE | $19.23 | -36.6K | 17.7K | -67% | -$703.0K |
| DM | 2021-09-22 | 2021-09-20+ | SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | Pres, COO, Dir | M - OptEx | $7.20 | +36.6K | 18.0K | New | +$263.3K |
| DM | 2021-09-15 | 2021-09-13+ | SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | Pres, COO, Dir | M - OptEx | $7.20 | +61.0K | 62.0K | +6,052% | +$439.2K |
| DM | 2021-09-15 | 2021-09-13+ | SNDX | Syndax Pharmaceuticals Inc | Metzger Michael A | Pres, COO, Dir | S - Sale+OE | $19.11 | -61.0K | 17.7K | -78% | -$1.17M |
Purchase Sale Sale after option exercise All abbreviations